Co-Diagnostics (CODX) Stock Price
Co-Diagnostics Price
Revenue has compounded at 51.2% per year over the past 10 years to 622,489.00 USD. Co-Diagnostics's net margin stands at -7,533.6%, down from 37.5% several years earlier. Analysts set a median price target of 1.28 USD, implying 16.4% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus.
Co-Diagnostics stock price
Co-Diagnostics business model & stock analysis
Frequently asked questions about Co-Diagnostics
Analysts currently set an average price target of 1.28 USD for the Co-Diagnostics stock (median: 1.28 USD), implying +16.4 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Co-Diagnostics stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Co-Diagnostics to generate revenue of 552,400.00 USD and earnings per share of -9.24 USD.
Converted at the current exchange rate, the Co-Diagnostics share trades at 0.97 EUR (1.10 USD).
The Co-Diagnostics share (CODX) is listed on 6 stock exchanges, including: NASDAQ (CODX), London (0A50.L), Frankfurt (C97.F), München (C97.MU), Düsseldorf (C97.DU), Hamburg (C97.HM).
The expected revenue of Co-Diagnostics is 552,400.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Co-Diagnostics is -12.28 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Co-Diagnostics is currently -0.12. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Co-Diagnostics stock.
The price-to-sales ratio (P/S) of Co-Diagnostics is currently 2.64. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Co-Diagnostics stock.
The Eulerpool Quality Score for Co-Diagnostics is 2/10.
The ISIN of Co-Diagnostics is US1897632048. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Co-Diagnostics is A2DU6V. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Co-Diagnostics is CODX. The ticker symbol is used to trade Co-Diagnostics shares on the stock exchange.
Co-Diagnostics stock
Co-Diagnostics Peer Group
Co-Diagnostics Ticker
All fundamentals and in-depth analysis of Co-Diagnostics
Our stock analysis for Co-Diagnostics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Co-Diagnostics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.